\(
\def\WIPO{World Intellectual Property Organisation}
\)
The distribution of patent impact in federal research: A citation analysis of LANL, SNL, and LLNL
2026
Форматы
| Формат | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS | |
Цитировать
Название
The distribution of patent impact in federal research: A citation analysis of LANL, SNL, and LLNL
Тип объекта
Journal article
Описание
1 volume.
Резюме
This research note analyzes forward citations for patents granted to the three largest U.S. National Laboratories: Los Alamos (LANL), Sandia (SNL), and Lawrence Livermore (LLNL). Using USPTO data from 2005 to 2021, we examine the rarity of high-impact inventions within the federal research system. Grounded in March's (1991) exploration-exploitation framework, we define an Innovation Lottery model where mission-driven R&D is characterized by extreme uncertainty and stochastic breakthroughs. Our results reveal a consistent power-law distribution across all three labs, with scaling exponents (alpha) ranging from 1.88 to 3.02. Sandia (SNL) exhibits the most heavy-tailed distribution (alpha = 1.88), suggesting a robust alignment with dual-use commercial cycles, while LLNL's rapid decay (alpha = 3.02) reflects the friction of highly specialized Big Science. We find that up to 67.7% of patents receive only a single citation, representing the necessary search costs of discovery. Conversely, a tiny fraction of Black Swan outliers accounts for the vast majority of technological spillovers. Aligning with May 2025 GAO findings regarding patent quality, we argue that volume-based KPIs are fundamentally misleading. We propose reforming technology transfer through tiered CRADA structures and success-based royalty recapture to better optimize the head of the impact distribution.
Source of Description
Crossref
Серии
World Patent Information ; 85, June, 2026
Цитата в журнале
World Patent Information
Взаимосвязанные ресурсы
Опубликовано
Oxford [England] : Elsevier Ltd., 2026.
Язык(и)
eng
Информация об авторском праве
https://www.sciencedirect.com/science/article/abs/pii/S0172219023000108
Запись имеется в